Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of sequential
chemoradiotherapy (induction chemotherapy + intensity-modulated radiotherapy +adjuvant
chemotherapy) with induction chemotherapy plus concurrent chemoradiotherapy in patients with
locoregionally advanced nasopharyngeal carcinoma (NPC), in order to confirm the value of
sequential chemoradiotherapy in NPC patients.
Phase:
Phase 3
Details
Lead Sponsor:
Chaosu Hu
Collaborators:
Affiliated Hospital of Jiangnan University First Affiliated Hospital of Wenzhou Medical University Fujian Cancer Hospital Jiangxi Provincial Cancer Hospital Zhejiang Cancer Hospital